Ben Kellogg’s Post

A question I get asked frequently by people unfamiliar with our platform is: where is the value add? What is it that makes Nuvolos special? The answer is simple: the value add is everywhere, and that is precisely what makes us so special. At every step of the process, we are improving, streamlining, simplifying, and accelerating every facet of your research, opening new windows of insight while bringing you to the finish line faster. The concept behind Nuvolos is not to be faster or more efficient or even better exactly. It is to redefine completely how we think about and conduct data-intensive, data-driven research. It’s about creating something new. Our mission at Nuvolos is to give research teams the freedom needed to make unique advancements in their area of expertise, to empower scientists to focus solely on breakthroughs instead of managing their tech. As our world and technology redefines what is possible, we must also reimagine not just how we interact with it, but how we think about it.   It’s time to usher in an innovative new era of research. Connect with me to learn more or set up a demo to see for yourself how Nuvolos is changing the world of data-driven research. #Biotech #ResearchInnovation #DataScience #DigitalTransformation #TechInnovation

We’ve had an incredible and busy month at RNAnalytics, and we’re excited to share some of our recent milestones with you! 🧬 Our new laboratory setup is now fully operational, setting the stage for groundbreaking research. 🧪🔬 We had a fantastic time showcasing our latest innovations at the Long Night of Research at the Makerspace, a night filled with insights and inspiration. 🌌✨ Engaging with the vibrant startup community at ViennaUP was truly inspiring as we presented our work and connected with innovators and visionaries. 🚀🤝 Attending aws Connect Day allowed us to network with industry leaders and explore exciting new collaboration opportunities. 🌐🤝 We’re diligently working on our Quality Management system, writing numerous SOPs to ensure compliance and efficiency in all our processes. 📋✅ Additionally, we received a crucial shipment of chemicals, enabling us to move forward with our experimental protocols and advance our research activities. 🧪📦 We’re thrilled about these developments and look forward to continuing our journey in innovation and excellence. Stay tuned for more updates! #RNAnalytics #GeneTherapy #Biotech #Innovation #Research #LabSetup #LNF2024 #ViennaUP #AWSConnectDay #QualityManagement #ResearchAndDevelopment #Science #Chemicals #LifeSciences #StartupCommunity #Networking

🚀 𝗙𝗼𝗿𝘄𝗮𝗿𝗱 𝗧𝗼𝘄𝗮𝗿𝗱 "𝗚𝗿𝗲𝗮𝘁 𝘁𝗵𝗶𝗻𝗴𝘀 𝗮𝗿𝗲 𝗻𝗼𝘁 𝗱𝗼𝗻𝗲 𝗯𝘆 𝗶𝗺𝗽𝘂𝗹𝘀𝗲, 𝗯𝘂𝘁 𝗯𝘆 𝗮 𝘀𝗲𝗿𝗶𝗲𝘀 𝗼𝗳 𝘀𝗺𝗮𝗹𝗹 𝘁𝗵𝗶𝗻𝗴𝘀 𝗯𝗿𝗼𝘂𝗴𝗵𝘁 𝘁𝗼𝗴𝗲𝘁𝗵𝗲𝗿." - Vincent Van Gogh Clinical research thrives on collaboration, persistence, and the courage to innovate. Every small contribution, whether refining a process, analyzing data, or brainstorming solutions, plays a crucial role in the larger mission of advancing healthcare. As we start this week, let’s focus on the power of incremental progress. Every step, no matter how small, brings us closer to transformative breakthroughs. This unwavering commitment to growth defines who we are at BioDev. Let’s make this week count - together, one step at a time! #ClinicalResearch #ForwardToward #Innovation #Teamwork

Techbio is so hard! 😅 😅 😅 1) you are discovering unexplored ground 2) the public market does not trust the pipeline yet 3) you need to invest massively in both the tech and the biotech side 4) but very few investor understand both (even if they claim to) 5) every discovery need lab validation 6) there is no other real proofpoint that a positive phase 2 or 3 trial 7) there is no company that is worth 100B+ in the field to show investors that it is possible. there is no "me too" companies with a twist in this space 8) the compliance and regulatory can be complicated 9) starting a trial is a big responsability : you want to be right for patients 10) language is just small part of the intelligence to build to decipher biology and a lot of other modalities are needed to build a biology AGI 11) you depend on pharma which can be painful sometime.. But you are building true impact - and anything you build won't copilot, but change the way we can treat disease. This is where you meet the most brilliant minds and engaged to play a social impact. And this is why I fucking love it and cannot do anything else.

Did you know that when we launched nearly six years ago, we estimated there were only about 90 people on the planet skilled at the intersection of #machinelearning and #proteinengineering? Hear our CEO Michael Nally discuss how #TeamGenerate is fostering a unique, collaborative culture in CorrDyn’s Data in Biotech interview with Ross Katz. Mike highlights how we blend computation, experimentation, and therapeutic development to drive innovation. Are you ready to span multiple disciplines and drive groundbreaking innovations? Explore career opportunities here: https://lnkd.in/gKaKkEGJ 👇 Watch the clip to hear more from Mike. #UnapologeticallyScientific | #IntrinsicallyDigital 

Our collaboration with Boston BioProducts enhances product visibility by integrating real-time citation data, empowering researchers to make informed decisions. Bioz Badges display detailed product usage information from within published research articles, providing unparalleled transparency and credibility. Meanwhile, the Bioz Content Hub serves as a powerful knowledge-base for researchers to access vital product insights and discover innovative tools for their scientific experiments. This is a huge leap forward in connecting science with data-driven solutions, helping suppliers and researchers alike. Check out the full details in our press release: https://lnkd.in/gVKEvDdn #Bioz #BostonBioProducts #ResearchInnovation #BiozBadges #BiozContentHub #LifeScience #CitationData #ScientificResearch #Innovation #LabTech #Biotech #BiozStars

What reasons prevent us from making Stanford Byers Center for Biodesign and similar programs the norm in every healthcare system and healthcare educational program, even in high schools? Congratulations to all the people involved in this type of program! #Biodesign #innovationeducation #healthtech #medtech #biotech #digitalhealth

🎉 Attention #Boston scientists and researchers, and even Marketers too 👀 🚀 For a limited time, enjoy 50% off on Science42: #DORA, the AI-powered research tool designed to supercharge your #dataanalysis and discovery process. 🔬 Whether you’re in #biotech or #academia, or prepping for an upcoming conference, DORA’s advanced capabilities help streamline complex research, making it an essential tool for the Boston scientific community. Take advantage of this exclusive offer and accelerate your discoveries! https://pharma.ai/dora #AIinScience #DrugDiscovery #BostonScience #Innovation #ResearchTools #Science42

Enhancing Collaborative Research Efforts Collaborating across disciplines and institutions can be incredibly rewarding but also challenging. Effective collaboration is crucial for innovation. Tip of the Day: Establish clear communication channels and regular check-ins to ensure all team members are on the same page. Use collaborative tools to streamline the process and keep track of progress. Join Bio Crew for more tips on building successful research collaborations! #CollaborativeResearch #TeamScience #BioCrew #ResearchNetworking #Innovation

🔥🔥🔥 First 𝟯𝟬 𝗽𝗶𝘁𝗰𝗵 𝘀𝗹𝗼𝘁𝘀 𝗴𝗿𝗮𝗻𝘁𝗲𝗱, 𝟲𝟬 slots 𝗮𝘃𝗮𝗶𝗹𝗮𝗯𝗹𝗲, 🅰🅿🅿🅻🆈 🅽🅾🆆! (𝘓𝘪𝘯𝘬 1𝘴𝘵 𝘤𝘰𝘮𝘮𝘦𝘯𝘵 𝘧𝘪𝘦𝘭𝘥 𝘣𝘦𝘭𝘰𝘸) 𝗪𝗵𝗮𝘁 𝘄𝗲 𝗼𝗳𝗳𝗲𝗿? 🚩 𝟯𝟬+ 𝗶𝗻𝘃𝗲𝘀𝘁𝗼𝗿𝘀 confirmed; 𝟭𝟬+ 𝗺𝗼𝗿𝗲 investors in the pipeline 🚩 Optional 𝗽𝗿𝗲-𝗰𝗼𝗻𝗳𝗲𝗿𝗲𝗻𝗰𝗲 𝗽𝗿𝗼𝗴𝗿𝗮𝗺: satellite events, keynote, walking dinner 🚩 Optional 𝗽𝗼𝘀𝘁-𝗰𝗼𝗻𝗳𝗲𝗿𝗲𝗻𝗰𝗲 𝗽𝗿𝗼𝗴𝗿𝗮𝗺: incl. a 𝘀𝘁𝘂𝗱𝘆 𝘃𝗶𝘀𝗶𝘁 & scale-up accelerator workshop at Bio Base Europe Pilot Plant in the framework of Pilots4U by CoPilot 🚩 SWAPCARD 𝗕𝟮𝗕 𝗼𝗻𝗹𝗶𝗻𝗲 𝗺𝗮𝘁𝗰𝗵𝗺𝗮𝗸𝗶𝗻𝗴 tool 🚩 Are you a bioeconomy innovator, pilot facility, a corporate or investor scouting for technologies or looking for partners, a service provider, a potential public project partner, a cluster, a public actor, a policy advisor, a consultant, a scientist or any other type of bioeconomy stakeholder? 𝗥𝗘𝗚𝗜𝗦𝗧𝗘𝗥 𝗡𝗢𝗪 𝗮𝗻𝗱 𝗷𝗼𝗶𝗻 𝘂𝘀 𝗳𝗼𝗿 𝗮 𝗳𝘂𝗹𝗹 𝗱𝗮𝘆 𝗼𝗳 𝗶𝗻𝘁𝗲𝗻𝘀𝗲 𝗰𝗿𝗼𝘀𝘀-𝗯𝗼𝗿𝗱𝗲𝗿 𝗻𝗲𝘁𝘄𝗼𝗿𝗸𝗶𝗻𝗴, 𝗶𝗻𝗻𝗼𝘃𝗮𝘁𝗶𝗼𝗻 𝘀𝗰𝗼𝘂𝘁𝗶𝗻𝗴 𝗮𝗻𝗱 𝗺𝗮𝘁𝗰𝗵𝗺𝗮𝗸𝗶𝗻𝗴.   🚩 Are you a Bio-Innovator or an Open Access Pilot & Demo Facility? 𝗖𝗵𝗲𝗰𝗸 𝗼𝘂𝘁 𝗼𝘂𝗿 𝗢𝗽𝗲𝗻 𝗖𝗮𝗹𝗹𝘀 to co-create the next database & platform of Open Access Pilot and Demo Infrastructures (Pilots4U by CoPilot). Get a 𝗴𝗿𝗮𝗻𝘁 𝗼𝗳 €𝟲,𝟬𝟬𝟬 and join us for the co-creation sessions on December 4th, 2024. 𝘔𝘰𝘳𝘦 𝘪𝘯𝘧𝘰: 1𝘴𝘵 𝘤𝘰𝘮𝘮𝘦𝘯𝘵 𝘧𝘪𝘦𝘭𝘥 𝘣𝘦𝘭𝘰𝘸. Co-organisers: Bio Base Europe Pilot Plant, Pilots4U by CoPilot, ShapingBio, The ProteInn Club, Planet B.io, biotope by VIB, Bio Invest Europe, INN-PRESSME and Enterprise Europe Network.